Clinical Trial Results

Showing 1-10 of 23

Sorted By:

  • A011401 BWEL (Breast)

    A Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer: Stage II /III within 1 year of diagnosis

  • A011502 ABC Trial (Breast)

    Phase III Randomized double blinded placebo-controlled trial of aspirin as adjuvant therapy for Her 2 Negative breast cancer STAGE II OR III

  • A021502 ATOMIC (Colon)

    A Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

  • A031501 AMBASSADOR (Urothelial)

    A Phase III Randomized Adjuvant Study of MK-3475 (PEMBROLIZUMAB) in Muscle Invasive and Locally Advanced Urothelial Carcinoma versus Observation

  • A051701 (Lymphoma)

    A Randomized Phase II/III Study of Venetoclax (ABT199) plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas

  • A151216 ALCHEMIST (Lung)

    Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST): A screening trial for A081105, E4512 and EA5142

  • DCP-001 (Any Cancer)

    Clinical trial DCP-001 at the Harold Alfond Center for Cancer Care: Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)


    A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib vs. Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

  • EA8143 PROSPER RCC (Renal)

    A Phase III RandOmized Study Comparing PERioperative NIVOLUMAB vs. OBSERVATION in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy

  • EA8153 CHAARTED2 (Prostate)

    Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel